Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,179
Total Claims
$729K
Drug Cost
161
Beneficiaries
$4,529
Cost/Patient
Risk Score Breakdown 36/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-33%
Opioid rate vs peers
1.5% vs 2.2% avg
+221%
Cost per patient vs peers
$4,529 vs $1,411 avg
+43%
Brand preference vs peers
15.2% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.5%
Opioid Rate
153
Opioid Claims
$14K
Opioid Cost
27.5%
Long-Acting Rate
Brand vs Generic
Brand: 1,538 claims · $524K
Generic: 8,555 claims · $199K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 501 | $109K |
| Teriparatide | 15 | $67K |
| Rivaroxaban | 124 | $31K |
| Mirabegron | 110 | $28K |
| Glatiramer Acetate | 12 | $23K |
| Brivaracetam | 19 | $20K |
| Brexpiprazole | 33 | $17K |
| Oxycodone Hcl | 39 | $12K |
| Insulin Lispro | 56 | $12K |
| Linagliptin | 33 | $8,722 |
| Insulin Glargine,hum.Rec.Anlog | 74 | $8,097 |
| Mesalamine | 25 | $7,818 |
| Sitagliptin Phosphate | 25 | $7,023 |
| Pen Needle,dual Safety,diabetc | 65 | $6,261 |
| Lidocaine | 46 | $5,292 |
Prescribing Profile
Patient Profile
87
Avg Age
74%
Female
2.07
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About